A selective SIRT2 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SirReal2

Item No. 18116

Technical Information
Formal Name
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-[5-(1-naphthalenylmethyl)-2-thiazolyl]-acetamide
CAS Number
709002-46-0
Molecular Formula
C22H20N4OS2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 3 mg/mlDMSO:PBS(pH 7.2) (1:2): 0.3 mg/ml
λmax
247, 282 nm
SMILES
CC1=NC(SCC(NC2=NC=C(CC3=C(C=CC=C4)C4=CC=C3)S2)=O)=NC(C)=C1
InChi Code
InChI=1S/C22H20N4OS2/c1-14-10-15(2)25-22(24-14)28-13-20(27)26-21-23-12-18(29-21)11-17-8-5-7-16-6-3-4-9-19(16)17/h3-10,12H,11,13H2,1-2H3,(H,23,26,27)
InChi Key
MENNDDDTIIZDDN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    SirReal2 is an aminothiazole that acts as a SIRT-rearranging ligand to selectively inhibit SIRT2 (IC50 = 140 nM).1 SirReal2 is >1,000-fold more potent at inhibiting the activity of SIRT2 than that of SIRT1 or SIRT3-6.1 This compound has been shown to be active in HeLa cells by significantly increasing α-tubulin acetylation.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rumpf, T., Schiedel, M., Karaman, B., et alSelective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nat. Commun. 6, (2015).